AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Human Longevity and Insilico Form New Venture to Build AI for Aging Biology
Human Longevity has launched a new company with Insilico Medicine to advance AI-powered longevity research. The partnership signals growing confidence that aging biology can become a structured drug discovery problem, not just a scientific frontier.
Insilico Says AI Is Shortening Drug Approval Timelines, but the Real Test Is Still in the Clinic
Insilico’s CEO argues that AI-powered drug discovery can significantly shorten approval timelines. The claim captures the optimism around generative discovery, but it also highlights the central issue in the field: speed in discovery does not automatically translate into faster clinical success. The real test is whether AI reduces the amount of dead-end biology entering the pipeline and improves the probability that candidates survive development.
Insilico and Servier Sign $888 Million AI Cancer Discovery Pact
Insilico Medicine and Servier have entered a cancer R&D collaboration valued at up to $888 million, with Insilico leading AI-driven discovery for challenging oncology targets and Servier handling clinical validation and commercialization. The deal underscores how major drugmakers are increasingly treating AI not as a side capability but as a front-end engine for target selection and molecule generation.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.